Abstract
TGF-β is thought to play a central role in pulmonary fibrosis inducing fibroblast differentiation and extracellular matrix synthesis. In human lung fibroblasts, it is still unclear how various TGB-β isoforms affect TGF-β production and whether glucocorticoids, commonly used agents to treat fibrotic lung disease, modulate these processes. To this end, human fetal lung fibroblasts (HFL-1) were cultured with various concentrations of glucocorticoids (budesonide, dexamethasone or hydrocortisone) with and without TFG-β1, -β2, and -β3. TGF-β mRNA was assessed by real time RT-PCR. Smad 2, 3, and 4 and AP-1 complex (c-fos and c-Jun) cellular localization were evaluated by immunostaining. TGF-β2 and -β3 stimulated TGF-β1 production significantly (p < 0.01 relative to control). TGF-β1 stimulated TGF-β2 production (p < 0.01 relative to control). TGF-β3 was undetectable. Glucocorticoids significantly inhibited TGF-β1 and -β2 production and reduced expression of the upregulated TGF-β1 and -β2 mRNA induced by exogenous TGF-β1, -β2 or -β3 (p < 0.01 for each) but had no effect on Smads. Although c-jun-related nuclear staining was not intensified in TGF-β-stimulated cells, it was reduced by glucocorticoids. Thus, TGF-β isoforms may stimulate production of various TGF-β isoforms in the lung. Glucocorticoids then may block TGF-β production by modulating mRNA levels and c-Jun.
Similar content being viewed by others
REFERENCES
Khalil, N. 1999. TGF-β: from latent to active. Microbes Infect. 1:1255–1263.
Blobe, G. C., W. P. Schiemann, and H. F Lodish. 2000. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342:1350–1358.
Roche, W. R., R. Beasley, J. H. Williams, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. i:520–524.
Jeffery, P. K., A. J. Wardlaw, F. C. Nelson, J. V. Colins, and A. B. Kay. 1989. Bronchial biopsies in asthma. Am. Rev. Respir. Dis. 140:1745–1753.
Rennard, S. 1997. Pathophysiological mechanisms of COPD. Eur. Respir. Rev. 7:206–210.
Westergren-Thorsson, G., J. Hernnas, B. Sarnstrand, A. Oldberg, D. Heinegard, and A. Malmstrom. 1993. Altered expression of small proteoglycans, collagen, and transforming growth factorbeta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J. Clin. Invest. 92:632–637.
Khalil, N., R. N. O'Connor, H. W. Unruh, P. W. Warren, K. C. Flanders, A. Kemp, O. H. Bereznay, and A. H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am. J. Respir. Cell. Mol. Biol. 5:155–162.
Myers, J. L. and A. L. Katzenstein. 1988. Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia. Chest. 94:1309–1311.
Kuhn, C. and J. A. McDonald. 1991. The roles of the myo-fibroblast in idiopathic pulmonary fibrosis. Am. J. Pathol. 138:1257–1265.
Sayiner, A., Z. A. Aytemur, M. Cirit, and I. Unsal. 2001. Systemic glucocorticoids in severe exacerbations of COPD. Chest. 119:726–730.
van der Molen, T., B. Meyboom-de Jong, H. H. Mulder, and D. S. Postma. 1998. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment. Am. J. Respir. Crit. Care Med. 158:121–125.
Simons, F. E. 1998. Benefits and risks of inhaled glucocorti coids in children with persistent asthma. J. Allergy Clin. Immunol. 102:S77–S84.
Ziesche, R., E Hofbauer, K. Wittmann, V. Petkov, and L. H. Block. 1999. A prelimary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Eng. J. Med. 341:1264–1269.
Epler, G. R. 2001. Bronchiolitis obliterans organizing pneumonia. Arch. Intern. Med. 161:158–164.
Wen, F. Q., C. M. Sköld, X. D. Liu, R. F. Ertl, Y. K. Zhu. T. Kohyama, H. Wang, and S. E. Rennard. 2001. Glucocorticoids and TGF-beta1 synergize in augmenting fibroblast mediated contraction of collagen gels. Inflammation. 25:109–117.
Skold, C. M., X. Liu, Y. K. Zhu, T. Umino. K. Takigawa, Y. Ohkuni, R. F. Ertl, J. R. Spurzem, D. J. Romberger, R. Brattsand, and S. I. Rennard. 1999. Glucocorticoids augment fibroblast mediated contraction of collagen gels by inhibition of endogenous PGE production. Proc. Assn. Am. Phys. 111:249–258.
Kim, S. J. P. Angel., R. Lafyatis, K. Hattori, K. Y. Kim, M. B. Sporn, M. Karin, and A. B. Roberts. 1990. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10:1492–1497.
Bascom, C. C., J. R. Wolfshohl, R. J. Coffey, Jr., L. Madisen, N. R. Webb, A. R. Purchio, R. Derynck, and H. L. Moses. 1989. Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol. Cell. Biol. 9:5508–5515.
Chomczynski, P. and N. Sacchi. 1987. Single-step method ofRNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156–159.
Kelley, J., S. Shull, J. J. Walsh, K. R. Cutroneo, and M. Absher. 1993. Autoinduction of transforming growth factor-beta in human lung fibroblasts. Am. J. Respir. Cell. Mol. Biol. 8:417–424.
Song, C.-Z., X. Tian, and T. D. Gelehrter. 1999. Glucocorticoids receptor inhibits transforming growth factor b signaling by directly targeting the transcriptional activation function of Smad3. PNAS. 96:11776f–11781.
Almawi, W. Y., H. N. Beyhum, A. A. Rahme, and M. J. Rieder. 1996. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60:563–572.
Letterio, J. J. and A. B. Roberts. 1996. Transforming growth factor-beta1-deficient mice: identification of isoform-specific activities in vivo. J. Leukoc. Biol. 59:769–774.
Letterio, J. J. and E. P. Bottinger. 1998. TGF-beta knockout and dominant-negative receptor transgenic mice. Miner Electrolyte Metab. 24:161–167.
Massague, J. 1998. TGF-beta signal transduction. Annu. Rev. Biochem. 67:753–791
Foitzik, K., R. Paus, T. Doetschman, and G. P. Dotto. 1999. The TGF-b2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev. Biol. 212:278–289.
Khalil, N., O. Bereznay, M. Sporn, and A. H. Greenberg. 1989. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:727–737.
Assoian, R. K. and M. B. Sporn. 1986. Type beta transforming growth factor in buman platelets: release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol. 102:1217–1223.
Seersholm, N., M. Wencker, N. Banik, K. Viskum, A. Dirksen, A. Kok-Jensen and N. Konietzko. 1997. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficience? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur. Respir. J. 10:2260–2263.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wen, FQ., Kohyama, T., Sköld, C.M. et al. Glucocorticoids Modulate TGF-β Production. Inflammation 26, 279–290 (2002). https://doi.org/10.1023/A:1021412601538
Issue Date:
DOI: https://doi.org/10.1023/A:1021412601538